| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
5e-20 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-15 |
| mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-07 |
| mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
7e-06 |
| mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
9e-06 |
| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-05 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
4e-05 |
| mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
4e-05 |